203 related articles for article (PubMed ID: 32061667)
1. Exploring predicted indirectly recognizable HLA epitopes (PIRCHE-II) in liver transplant recipients on calcineurin inhibitor-free maintenance immunosuppression. A retrospective single center study.
Meszaros M; Niemann M; Ursic-Bedoya J; Faure S; Meunier L; Rivière B; Costes-Martineau V; Thevenin C; Pageaux GP
Transpl Immunol; 2020 Apr; 59():101272. PubMed ID: 32061667
[TBL] [Abstract][Full Text] [Related]
2. Donor-Recipient Matching Based on Predicted Indirectly Recognizable HLA Epitopes Independently Predicts the Incidence of De Novo Donor-Specific HLA Antibodies Following Renal Transplantation.
Lachmann N; Niemann M; Reinke P; Budde K; Schmidt D; Halleck F; Pruß A; Schönemann C; Spierings E; Staeck O
Am J Transplant; 2017 Dec; 17(12):3076-3086. PubMed ID: 28613392
[TBL] [Abstract][Full Text] [Related]
3. Can PIRCHE-II Matching Outmatch Traditional HLA Matching?
Unterrainer C; Döhler B; Niemann M; Lachmann N; Süsal C
Front Immunol; 2021; 12():631246. PubMed ID: 33717167
[TBL] [Abstract][Full Text] [Related]
4. Association between PIRCHE-II scores and de novo allosensitization after reduction of immunosuppression during SARS-CoV-2 infection in kidney transplant recipients.
Castrezana-Lopez K; Malchow R; Nilsson J; Kokkonen SM; Rho E; von Moos S; Mueller TF; Schachtner T
Transpl Infect Dis; 2023 Apr; 25(2):e14052. PubMed ID: 36884207
[TBL] [Abstract][Full Text] [Related]
5. Predictive value of HLAMatchmaker and PIRCHE-II scores for de novo donor-specific antibody formation after adult and pediatric liver transplantation.
Hamada S; Dumortier J; Thévenin C; Pageaux GP; Faure S; Guillaud O; Boillot O; Lachaux A; Luscalov DA; Dubois V; Meszaros M
Transpl Immunol; 2020 Aug; 61():101306. PubMed ID: 32422222
[TBL] [Abstract][Full Text] [Related]
6. Impact of calcineurin inhibitor-free immunosuppression on de novo donor-specific antibody formation in liver transplant recipients.
Meszaros M; Dubois V; Congy-Jolivet N; Hamada S; Thevenin C; Faure S; Boillot O; Kamar N; Pageaux GP; Del Bello A; Dumortier J
Liver Int; 2022 May; 42(5):1132-1143. PubMed ID: 35184373
[TBL] [Abstract][Full Text] [Related]
7. PIRCHE-II Is Related to Graft Failure after Kidney Transplantation.
Geneugelijk K; Niemann M; Drylewicz J; van Zuilen AD; Joosten I; Allebes WA; van der Meer A; Hilbrands LB; Baas MC; Hack CE; van Reekum FE; Verhaar MC; Kamburova EG; Bots ML; Seelen MAJ; Sanders JS; Hepkema BG; Lambeck AJ; Bungener LB; Roozendaal C; Tilanus MGJ; Vanderlocht J; Voorter CE; Wieten L; van Duijnhoven EM; Gelens M; Christiaans MHL; van Ittersum FJ; Nurmohamed A; Lardy JNM; Swelsen W; van der Pant KA; van der Weerd NC; Ten Berge IJM; Bemelman FJ; Hoitsma A; van der Boog PJM; de Fijter JW; Betjes MGH; Heidt S; Roelen DL; Claas FH; Otten HG; Spierings E
Front Immunol; 2018; 9():321. PubMed ID: 29556227
[TBL] [Abstract][Full Text] [Related]
8. Analysis of T and B Cell Epitopes to Predict the Risk of
Sakamoto S; Iwasaki K; Tomosugi T; Niemann M; Spierings E; Miwa Y; Horimi K; Takeda A; Goto N; Narumi S; Watarai Y; Kobayashi T
Front Immunol; 2020; 11():2000. PubMed ID: 32973806
[TBL] [Abstract][Full Text] [Related]
9. Association of Predicted HLA T-Cell Epitope Targets and T-Cell-Mediated Rejection After Kidney Transplantation.
Senev A; Van Loon E; Lerut E; Coemans M; Callemeyn J; Daniëls L; Kerkhofs J; Koshy P; Kuypers D; Lamarthée B; Sprangers B; Tinel C; Van Craenenbroeck AH; Van Sandt V; Emonds MP; Naesens M
Am J Kidney Dis; 2022 Dec; 80(6):718-729.e1. PubMed ID: 35690154
[TBL] [Abstract][Full Text] [Related]
10. Association of HLA B- and T-cell molecular mismatches with HLA antibodies, rejection, and graft survival in pediatric kidney transplantation.
Gramkow AM; Baatrup JH; Gramkow ET; Thiesson HC; Koefoed-Nielsen P
Pediatr Transplant; 2024 Aug; 28(5):e14773. PubMed ID: 38808702
[TBL] [Abstract][Full Text] [Related]
11. Exploratory Study of Predicted Indirectly ReCognizable HLA Epitopes in Mismatched Hematopoietic Cell Transplantations.
Geneugelijk K; Thus KA; van Deutekom HWM; Calis JJA; Borst E; Keşmir C; Oudshoorn M; van der Holt B; Meijer E; Zeerleder S; de Groot MR; von dem Borne PA; Schaap N; Cornelissen J; Kuball J; Spierings E
Front Immunol; 2019; 10():880. PubMed ID: 31068946
[TBL] [Abstract][Full Text] [Related]
12. T-Cell Epitopes Shared Between Immunizing HLA and Donor HLA Associate With Graft Failure After Kidney Transplantation.
Peereboom ETM; Matern BM; Tomosugi T; Niemann M; Drylewicz J; Joosten I; Allebes WA; van der Meer A; Hilbrands LB; Baas MC; van Reekum FE; Verhaar MC; Kamburova EG; Seelen MAJ; Sanders JS; Hepkema BG; Lambeck AJ; Bungener LB; Roozendaal C; Tilanus MGJ; Voorter CE; Wieten L; van Duijnhoven EM; Gelens MACJ; Christiaans MHL; van Ittersum FJ; Nurmohamed A; Lardy NM; Swelsen W; van der Pant KA; van der Weerd NC; Ten Berge IJM; Bemelman FJ; de Vries APJ; de Fijter JW; Betjes MGH; Roelen DL; Claas FH; Otten HG; Heidt S; van Zuilen AD; Kobayashi T; Geneugelijk K; Spierings E
Front Immunol; 2021; 12():784040. PubMed ID: 34868064
[TBL] [Abstract][Full Text] [Related]
13. PIRCHE-II scores prove useful as a predictive biomarker among kidney transplant recipients with rejection: An analysis of indication and follow-up biopsies.
Spitznagel T; Matter LS; Kaufmann YL; Nilsson J; von Moos S; Schachtner T
Front Immunol; 2022; 13():949933. PubMed ID: 36059499
[TBL] [Abstract][Full Text] [Related]
14. Assessment of human leukocyte antigen matching algorithm PIRCHE-II on liver transplantation outcomes.
Kok G; Verstegen MMA; Houwen RHJ; Nieuwenhuis EES; Metselaar HJ; Polak WG; van der Laan LJW; Spierings E; den Hoed CM; Fuchs SA
Liver Transpl; 2022 Aug; 28(8):1356-1366. PubMed ID: 35152544
[TBL] [Abstract][Full Text] [Related]
15. Human leukocyte antigen epitope mismatch loads and the development of de novo donor-specific antibodies in cardiothoracic organ transplantation.
Bedford A; Jervis S; Worthington J; Lowe M; Poulton K
Int J Immunogenet; 2022 Feb; 49(1):30-38. PubMed ID: 34904369
[TBL] [Abstract][Full Text] [Related]
16. Donor/Recipient HLA Molecular Mismatch Scores Predict Primary Humoral and Cellular Alloimmunity in Kidney Transplantation.
Meneghini M; Crespo E; Niemann M; Torija A; Lloberas N; Pernin V; Fontova P; Melilli E; Favà A; Montero N; Manonelles A; Cruzado JM; Palou E; Martorell J; Grinyó JM; Bestard O
Front Immunol; 2020; 11():623276. PubMed ID: 33776988
[TBL] [Abstract][Full Text] [Related]
17. Refinement of the definition of permissible HLA-DPB1 mismatches with predicted indirectly recognizable HLA-DPB1 epitopes.
Thus KA; Ruizendaal MT; de Hoop TA; Borst E; van Deutekom HW; Te Boome L; Kuball J; Spierings E
Biol Blood Marrow Transplant; 2014 Nov; 20(11):1705-10. PubMed ID: 24980111
[TBL] [Abstract][Full Text] [Related]
18. PIRCHE-II: an algorithm to predict indirectly recognizable HLA epitopes in solid organ transplantation.
Geneugelijk K; Spierings E
Immunogenetics; 2020 Feb; 72(1-2):119-129. PubMed ID: 31741009
[TBL] [Abstract][Full Text] [Related]
19. HLA-DQ mismatches stimulate de novo donor specific antibodies in heart transplant recipients.
Zhang X; Kransdorf E; Levine R; Patel JK; Kobashigawa JA
Hum Immunol; 2020 Jul; 81(7):330-336. PubMed ID: 32307126
[TBL] [Abstract][Full Text] [Related]
20. Early progression of chronic histologic lesions in kidney transplant biopsies is not associated with HLA histocompatibility.
Jabbour R; Heinzel A; Reindl-Schwaighofer R; Gregorich MG; Regele H; Kozakowski N; Kläger J; Fischer G; Kainz A; Becker JU; Wiebe C; Oberbauer R
Nephrol Dial Transplant; 2024 Apr; 39(5):808-817. PubMed ID: 37960919
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
